EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Impact of Metabolic Rewiring in Glioblastoma: The Immune Landscape and Therapeutic Strategies

Yuganthini Vijayanathan, Ivy A W Ho iD

International Journal of Molecular Sciences · 14.01.2025 · 26 (2) · 669

DOI: 10.3390/ijms26020669 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 14.01.2025. Verfasst von Yuganthini Vijayanathan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Neurotherapeutics Laboratory, National Neuroscience Institute, Singapore 308433, Singapore. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms. Die Arbeit wurde bisher 47-mal zitiert (Crossref) und nennt 212 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Singapore Ministry of Health's National Medical Research Council, SingHealth Duke-NUS Academic Medicine Research Grant, Singapore Ministry of Health’s National Medical Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM) is an aggressive brain tumor characterized by extensive metabolic reprogramming that drives tumor growth and therapeutic resistance. Key metabolic pathways, including glycolysis, lactate production, and lipid metabolism, are upregulated to sustain tumor survival in the hypoxic and nutrient-deprived tumor microenvironment (TME), while glutamine and tryptophan metabolism further contribute to the aggressive phenotype of GBM. These metabolic alterations impair immune cell function, leading to exhaustion and stress in CD8+ and CD4+ T cells while favoring immunosuppressive populations such as regulatory T cells (Tregs) and M2-like macrophages. Recent studies emphasize the role of slow-cycling GBM cells (SCCs), lipid-laden macrophages, and tumor-associated astrocytes (TAAs) in reshaping GBM’s metabolic landscape and reinforcing immune evasion. Genetic mutations, including Isocitrate Dehydrogenase (IDH) mutations, Epidermal Growth Factor Receptor (EGFR) amplification, and Phosphotase and Tensin Homolog (PTEN) loss, further drive metabolic reprogramming and offer potential targets for therapy. Understanding the relationship between GBM metabolism and immune suppression is critical for overcoming therapeutic resistance. This review focuses on the role of metabolic rewiring in GBM, its impact on the immune microenvironment, and the potential of combining metabolic targeting with immunotherapy to improve clinical outcomes for GBM patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlioblastomaBrain NeoplasmsHumansTumor MicroenvironmentAnimalsImmunotherapy

Stichwörter der Autor:innen

GBMgliomaimmune infiltrationmetabolismtumor microenvironment

Autor:innen und Institutionen

  • Molecular Neurotherapeutics Laboratory, National Neuroscience Institute, Singapore 308433, Singapore.
  • Duke-NUS Medical School, Singapore 169857, Singapore.
  • Department of Physiology, National University of Singapore, Singapore 117593, Singapore.

ORCID-Profile: Ivy A W Ho

Förderung

  • Singapore Ministry of Health's National Medical Research Council
  • SingHealth Duke-NUS Academic Medicine Research Grant
  • Singapore Ministry of Health’s National Medical Research Council

Zitieren

APA

Vijayanathan, Y., & Ho, I. A. W. (2025). The Impact of Metabolic Rewiring in Glioblastoma: The Immune Landscape and Therapeutic Strategies. International Journal of Molecular Sciences, 26(2), 669. https://doi.org/10.3390/ijms26020669

Vancouver

Vijayanathan Y, Ho IAW. The Impact of Metabolic Rewiring in Glioblastoma: The Immune Landscape and Therapeutic Strategies. International Journal of Molecular Sciences. 2025;26(2):669. doi:10.3390/ijms26020669

BibTeX
@article{Vijayanathan2025,
  author = {Vijayanathan, Yuganthini and Ho, Ivy A W},
  title = {The Impact of Metabolic Rewiring in Glioblastoma: The Immune Landscape and Therapeutic Strategies},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  volume = {26},
  number = {2},
  pages = {669},
  doi = {10.3390/ijms26020669}
}
Kostenlos starten →